维普期刊资源整合服务平台（V6.5）

152篇 您的检索式：作者名="Besarab"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Catheter management in hemodialysis patients:delivering adequate flow显示文摘	Besarab A Pandey R	2011	Clin J Am Soc Nephrol2011，6，：	1
2	Simplifying anemia management in hemodialysis patients: ESAs administered at longer dosing intervals can enhance opportunities to provide patient-focused care显示文摘	Schiller B Besarab A	2011	Curr Med Res Opin2011，27，：	1
3	Access monitoring is worthwhile and valuable显示文摘	BESARAB A	2006	Blood Purif2006，24，1：	1
4	Access monitoring is worthwhile and valuable显示文摘	Besarab A	2006	Blood Purif2006，24，1：	1
5	Dynamics of erythropoi- esis following renal transplantatlon显示文摘	Besarab A Caro J Jarrell BE	1987	Kidney Int1987，32，4：	1
6	The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin显示文摘	Besarab A Bolton WK Browne JK	1998	N Engl J Med1998，339，9：	1
7	The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin显示文摘	Besarab A BoltonWK Browne JK	1998	N Engl J Med1998，339，9：	1
8	The effect of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoietin显示文摘	Besarab A Bolton WK Browne JK	1998	N Engl J Med1998，33，9：	1
9	Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS):performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines显示文摘	Rayner HC Besarab A Brown WW	2004	Am J Kidney Dis2004，44，：	1
10	Optimization of epoietin therapy with intravenous iron therapy in hemodialysis patients显示文摘	Besarab A Amin N Ahsan M		0，，03：	1
11	Iron supplementation to treat anemia in patients with chronic kidney disease显示文摘	Besarab A Coyne DW	2010	Nat Rev Nephrol2010，12，7：	1
12	Recombinant Human erythropoietin: physiology, pathophysiology of anemia in renal failure and economic aspects to dosing显示文摘		1990	Am J Nephrol1990，10，2：	1
13	Dialysis iron therapy:Infusion of soluble ferric pyrophosphate via the dialysate during hemodialysis显示文摘	Gupta A Amin NB Besarab A	1999	Kidney Int1999，55，：	1
14	Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients 显示文摘	Besarab A Amin N Ahsan M	2000	J Am Soc Nephrol2000，11，3：	1
15	An indistinct balance: safety and efficacy of parenteral iron显示文摘	Besarab A Frinak S Yee J	1999	J Am Soc Nephol1999，10，9：	1
16	The Soci- ety for Vascular Surgery: clinical practice guide- lines for the surgical placement and maintenance of arteriovenous hemodialysis access显示文摘	Sidawy A N Spergel L M Besarab A	2008	J Vasc Surg2008，48，5：	1
17	The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin显示文摘	Besarab A Bolton W K Browne J K		0，，09：	1
18	An open-label,sequential,dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients显示文摘	Besarab A Zeig S N Martin E R Pergola P E Whittier F C Zabaneh R I	2012	BMC Nephrol2012，13，：	1
19	Catheter management in hemodialysispatients; delivering adequate flow 显示文摘	Besarab A Pandey R	2011	Clin J Am Soc Nephrol2011，6，1：	1
20	Utility of intraaccess pressure monitoring in detecting and correcting venous outlet stenoses prior to thrombosis显示文摘	Besarab A Sullivan KL Ross RP	1995	Kidney Int1995，47，：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示